Rocket Pharmaceuticals (RCKT) Institutional Ownership $3.28 -0.07 (-2.09%) Closing price 08/29/2025 04:00 PM EasternExtended Trading$3.28 0.00 (0.00%) As of 08/29/2025 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Rocket Pharmaceuticals (NASDAQ:RCKT)CurrentInstitutional OwnershipPercentage98.39%Number ofInstitutional Buyers(last 12 months)164TotalInstitutional Inflows(last 12 months)$387.04MNumber ofInstitutional Sellers(last 12 months)57TotalInstitutional Outflows(last 12 months)$100.22M Get RCKT Insider Trade Alerts Want to know when executives and insiders are buying or selling Rocket Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Chart & View Institutional Buying and Selling Data RCKT Institutional Buying and Selling by Quarter Rocket Pharmaceuticals Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/19/2025 Marex Group plc22,500$55K0.0%N/A0.021% 8/18/2025 Hudson Bay Capital Management LP27,400$67K0.0%-81.9%0.025% 8/15/2025 CANADA LIFE ASSURANCE Co12,202$29K0.0%+94.4%0.011% 8/15/2025 Tower Research Capital LLC TRC 23,258$57K0.0%+645.4%0.022% 8/15/2025 Corient Private Wealth LLC22,897$56K0.0%N/A0.021% 8/15/2025 Voleon Capital Management LP40,027$98K0.0%N/A0.037% 8/15/2025 Oxford Asset Management LLP54,801$134K0.0%+345.2%0.051% 8/15/2025 Hudson Bay Capital Management LP27,400$67K0.0%-81.9%0.025% 8/15/2025 Gilder Gagnon Howe & Co. LLC22,510$55K0.0%N/A0.021% 8/15/2025 Engineers Gate Manager LP264,203$647K0.0%+1,156.5%0.245% Get the Latest News and Ratings for RCKT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Rocket Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 8/15/2025 BNP Paribas Financial Markets454,640$1.11M0.0%+239.6%0.421% 8/15/2025 Bank of America Corp DE467,105$1.14M0.0%+10.8%0.433% 8/14/2025 MPM Bioimpact LLC3,903,081$9.56M1.7%+141.2%3.617% 8/14/2025 PDT Partners LLC265,982$652K0.0%N/A0.247% 8/14/2025 Raymond James Financial Inc.122,670$301K0.0%+288.5%0.114% 8/14/2025 Maverick Capital Ltd.8,363,813$20.49M0.3%+60.9%7.751% 8/14/2025 Occudo Quantitative Strategies LP184,658$452K0.1%N/A0.171% 8/14/2025 MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.112,382$275K0.0%-36.9%0.104% 8/14/2025 The Manufacturers Life Insurance Company 175,703$430K0.0%+13.6%0.163% 8/14/2025 Nebula Research & Development LLC100,780$247K0.0%N/A0.093% 8/14/2025 Qube Research & Technologies Ltd1,548,262$3.79M0.0%+690.8%1.435% 8/14/2025 Voss Capital LP500,000$1.23M0.1%+15.7%0.463% 8/14/2025 Federated Hermes Inc.624,303$1.53M0.0%+50.6%0.579% 8/13/2025 Jump Financial LLC437,295$1.07M0.0%+72.4%0.405% 8/13/2025 Tema Etfs LLC32,030$78K0.0%-13.1%0.030% 8/13/2025 Walleye Capital LLC576,051$1.41M0.0%+100.7%0.534% 8/13/2025 Invesco Ltd.111,004$272K0.0%-72.3%0.103% 8/13/2025 Virtus Investment Advisers LLC30,630$75K0.0%+134.6%0.028% 8/13/2025 Quadrature Capital Ltd92,592$226K0.0%N/A0.086% 8/12/2025 XTX Topco Ltd134,445$329K0.0%+290.7%0.125% 8/12/2025 Prudential Financial Inc.10,165$25K0.0%N/A0.009% 8/12/2025 Rhumbline Advisers120,282$295K0.0%+11.7%0.111% 8/12/2025 Legal & General Group Plc71,466$175K0.0%-41.7%0.066% 8/12/2025 JPMorgan Chase & Co.1,207,802$2.96M0.0%+98.0%1.119% 8/12/2025 Amitell Capital Pte Ltd227,000$556K0.3%N/A0.210% 8/11/2025 Intrust Bank NA10,840$27K0.0%-31.4%0.010% 8/8/2025 Rockefeller Capital Management L.P.96,982$238K0.0%+7.3%0.091% 8/8/2025 Creative Planning43,471$107K0.0%-45.4%0.041% 8/8/2025 Geode Capital Management LLC2,030,891$4.98M0.0%+1.8%1.902% 8/8/2025 PNC Financial Services Group Inc.10,767$26K0.0%-47.9%0.010% Why Trump’s “Smart Dollar” could rewrite the rules (Ad)MUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's latest plans for the dollar – and they're so bold that one central bank chair says we haven't seen anything like it in almost a century. Our Wall Street insider says it's the start of a once-in-a-lifetime investing opportunity, IF you act now.Get the three steps to take this month to put yourself on the right side of this $30 trillion money8/8/2025 Quinn Opportunity Partners LLC100,000$245K0.0%N/A0.094% 8/7/2025 Pier 88 Investment Partners LLC11,380$28K0.0%-80.0%0.011% 8/7/2025 Monaco Asset Management SAM452,767$1.11M0.2%N/A0.424% 8/7/2025 Rathbones Group PLC20,000$49K0.0%-33.3%0.019% 8/7/2025 Mitsubishi UFJ Asset Management Co. Ltd.36,185$89K0.0%+65.3%0.034% 8/7/2025 Los Angeles Capital Management LLC74,917$184K0.0%N/A0.070% 8/6/2025 Savant Capital LLC18,837$46K0.0%N/A0.018% 8/5/2025 Corton Capital Inc.15,495$38K0.0%N/A0.015% 8/5/2025 Bank of Montreal Can73,800$181K0.0%N/A0.069% 8/1/2025 May Hill Capital LLC19,939$49K0.0%N/A0.019% 7/31/2025 AlphaQuest LLC28,236$69K0.0%-70.7%0.026% 7/29/2025 VIRGINIA RETIREMENT SYSTEMS ET Al17,400$43K0.0%N/A0.016% 7/29/2025 Nordea Investment Management AB263,746$659K0.0%+3.7%0.247% 7/28/2025 TD Asset Management Inc174,910$429K0.0%+7.5%0.164% 7/25/2025 Vanguard Personalized Indexing Management LLC12,351$30K0.0%-37.6%0.012% 7/24/2025 Blair William & Co. IL104,211$255K0.0%-6.5%0.098% 7/21/2025 111 Capital22,592$55K0.0%N/A0.021% 7/18/2025 PFG Investments LLC18,100$44K0.0%+35.1%0.017% 7/11/2025 Farther Finance Advisors LLC13,540$33K0.0%+7,818.1%0.013% 7/10/2025 Sovran Advisors LLC196,028$480K0.1%-39.3%0.184% 6/27/2025 Goldman Sachs Group Inc.995,690$6.64M0.0%+24.0%0.932% 5/29/2025 Rhumbline Advisers107,638$718K0.0%+8.4%0.101% 5/23/2025 Siren L.L.C.591,263$3.94M0.2%-1.5%0.554% 5/16/2025 Goldman Sachs Group Inc.995,690$6.64M0.0%+24.0%0.932% 5/16/2025 Dynamic Technology Lab Private Ltd28,370$189K0.0%N/A0.027% 5/16/2025 Millennium Management LLC747,147$4.98M0.0%+121.8%0.700% 5/16/2025 EFG Asset Management North America Corp.110,961$737K0.1%-23.8%0.104% 5/16/2025 AQR Capital Management LLC163,622$1.09M0.0%+148.4%0.153% 5/16/2025 ADAR1 Capital Management LLC241,800$1.61M0.3%+14.4%0.226% 5/15/2025 MPM Bioimpact LLC1,618,265$10.79M1.9%+58.6%1.515% 5/15/2025 Frazier Life Sciences Management L.P.1,079,025$7.20M0.3%-27.0%1.010% 5/15/2025 Baker BROS. Advisors LP1,097,079$7.32M0.1%+1,030.1%1.027% 5/15/2025 Nantahala Capital Management LLC629,749$4.20M0.2%N/A0.590% 5/15/2025 Magnetar Financial LLC12,877$86K0.0%N/A0.012% 5/15/2025 Siren L.L.C.591,263$3.94M0.2%-1.5%0.554% 5/15/2025 Tema Etfs LLC36,863$246K0.1%-59.5%0.035% 5/15/2025 Trexquant Investment LP37,613$251K0.0%N/A0.035% 5/14/2025 Ieq Capital LLC24,275$162K0.0%N/A0.023% 5/14/2025 Corebridge Financial Inc.37,757$252K0.0%+15.4%0.035% 5/14/2025 Comerica Bank815,989$5.44M0.0%+4.6%0.764% 5/14/2025 MetLife Investment Management LLC45,858$306K0.0%+13.3%0.043% 5/14/2025 Synovus Financial Corp278,450$1.86M0.0%+69.9%0.261% 5/14/2025 Walleye Capital LLC287,088$1.92M0.0%+30.4%0.269% 5/14/2025 Jump Financial LLC253,723$1.69M0.0%N/A0.238% 5/14/2025 AlphaQuest LLC96,391$643K0.1%+344.5%0.090% 5/14/2025 EntryPoint Capital LLC76,419$510K0.2%+206.9%0.072% 5/14/2025 Voss Capital LP432,240$2.88M0.2%+2.5%0.405% 5/14/2025 Hsbc Holdings PLC10,583$69K0.0%N/A0.010% 5/14/2025 Wellington Management Group LLP12,626,491$84.22M0.0%-9.8%11.824% 5/14/2025 Cornerstone Select Advisors LLC22,265$149K0.1%+16.9%0.021% Why Trump’s “Smart Dollar” could rewrite the rules (Ad)MUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's latest plans for the dollar – and they're so bold that one central bank chair says we haven't seen anything like it in almost a century. Our Wall Street insider says it's the start of a once-in-a-lifetime investing opportunity, IF you act now.Get the three steps to take this month to put yourself on the right side of this $30 trillion money5/13/2025 Algert Global LLC55,510$370K0.0%+38.6%0.052% 5/13/2025 Fox Run Management L.L.C.18,047$120K0.0%N/A0.017% 5/13/2025 E Fund Management Co. Ltd.14,567$97K0.0%+31.8%0.014% 5/13/2025 Russell Investments Group Ltd.24,658$164K0.0%-96.9%0.023% 5/13/2025 HighTower Advisors LLC20,700$138K0.0%+16.6%0.019% 5/12/2025 Nuveen LLC178,293$1.19M0.0%N/A0.167% 5/12/2025 Entropy Technologies LP24,612$164K0.0%N/A0.023% 5/12/2025 Invesco Ltd.400,969$2.67M0.0%+12.1%0.375% 5/12/2025 Mitsubishi UFJ Asset Management Co. Ltd.21,885$146K0.0%+8.4%0.020% 5/9/2025 Deutsche Bank AG71,470$477K0.0%+12.1%0.067% (Data available from 1/1/2016 forward) RCKT Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of RCKT shares? During the previous two years, 222 institutional investors and hedge funds held shares of Rocket Pharmaceuticals. The most heavily invested institutionals were Wellington Management Group LLP ($84.22M), State Street Corp ($57.29M), Janus Henderson Group PLC ($50.34M), Vanguard Group Inc. ($44.14M), Price T Rowe Associates Inc. MD ($39.58M), Suvretta Capital Management LLC ($32.27M), and Westfield Capital Management Co. LP ($32.15M).Learn more on Rocket Pharmaceuticals' institutional investors. What percentage of Rocket Pharmaceuticals' stock is owned by institutional investors? 98.39% of Rocket Pharmaceuticals' stock is owned by institutional investors. Learn more on RCKT's institutional investor holdings. Which institutional investors have been buying Rocket Pharmaceuticals' stock? Of the 200 institutional investors that purchased Rocket Pharmaceuticals' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Wellington Management Group LLP ($7.89M), Janus Henderson Group PLC ($3.76M), Maverick Capital Ltd. ($3.39M), MPM Bioimpact LLC ($2.88M), Suvretta Capital Management LLC ($2.57M), Toronto Dominion Bank ($2.20M), and Vanguard Group Inc. ($1.93M). How much institutional buying is happening at Rocket Pharmaceuticals? Institutional investors have bought a total of 40,485,282 shares in the last 24 months. This purchase volume represents approximately $387.04M in transactions. Which of Rocket Pharmaceuticals' major shareholders have been selling company stock? Of the 57 institutional investors that sold Rocket Pharmaceuticals' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Wellington Management Group LLP ($1.37M), Franklin Resources Inc. ($1.22M), Janus Henderson Group PLC ($1.02M), Bamco Inc. NY ($904.33K), Millennium Management LLC ($865.59K), Russell Investments Group Ltd. ($787.65K), and Frazier Life Sciences Management L.P. ($482.21K). How much institutional selling is happening at Rocket Pharmaceuticals? Institutional investors have sold a total of 9,262,959 shares in the last 24 months. This volume of shares sold represents approximately $100.22M in transactions. Related Companies EWTX Institutional Ownership SDGR Institutional Ownership AVDL Institutional Ownership ARDX Institutional Ownership JANX Institutional Ownership HROW Institutional Ownership VERA Institutional Ownership AMPH Institutional Ownership SNDX Institutional Ownership ETNB Institutional Ownership This page (NASDAQ:RCKT) was last updated on 9/1/2025 by MarketBeat.com Staff From Our PartnersNew Banking Law #1582 Could Unlock $21 Trillion for AmericansDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe $365M annual revenue crypto play While Bitcoin generates zero operational revenue, one DeFi protocol qu...Crypto 101 Media | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredOne tiny company just cracked Google’s $19B problemAn MIT lab recently cracked a code scientists had been chasing for decades… Turning a “miracle metal” from ...True Market Insiders | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…A new set of 7 AI stocks are DOMINATING the market. Here’s why one financial guru says they could be the mo...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Rocket Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Rocket Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.